While Aclaris Therapeutics Inc has underperformed by -1.53%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ACRS rose by 195.41%, with highs and lows ranging from $5.17 to $0.80, whereas the simple moving average jumped by 110.99% in the last 200 days.
On November 20, 2024, Cantor Fitzgerald Upgraded Aclaris Therapeutics Inc (NASDAQ: ACRS) to Overweight. A report published by Leerink Partners on November 19, 2024, Upgraded its rating to ‘Outperform’ for ACRS. Jefferies also Upgraded ACRS shares as ‘Buy’, setting a target price of $7 on the company’s shares in a report dated November 19, 2024. Piper Sandler November 18, 2024d its ‘Neutral’ rating to ‘Overweight’ for ACRS, as published in its report on November 18, 2024. William Blair also rated the stock as ‘Mkt Perform’.
Analysis of Aclaris Therapeutics Inc (ACRS)
Further, the quarter-over-quarter decrease in sales is -53.18%, showing a negative trend in the upcoming months.
In order to gain a clear picture of Aclaris Therapeutics Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -25.83% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.03, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 2.26M can be a very valuable indicator of volatility for ACRS stock. On a monthly basis, the volatility of the stock is set at 13.92%, whereas on a weekly basis, it is put at 8.47%, with a loss of -18.27% over the past seven days. Furthermore, long-term investors anticipate a median target price of $7.60, showing growth from the present price of $3.22, which can serve as yet another indication of whether ACRS is worth investing in or should be passed over.
How Do You Analyze Aclaris Therapeutics Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 16.15%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 75.64% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ACRS shares are owned by institutional investors to the tune of 75.64% at present.
